Jasper Therapeutics
PublicJasper Therapeutics is now publicly traded
The data on this page reflects Jasper Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
PIPE
Jul 21, 2026
Total Funding Raised
$132M
Company Overview
Jasper Therapeutics operates in Biotech and is based in Redwood City, California. It has raised $132M.
Jasper Therapeutics is a biotechnology company that develops monoclonal antibody therapies for chronic mast cell-driven diseases and hematopoietic stem cell transplantation.
Sector
Biotech
AI Layer
Non-AI
Jasper Therapeutics Comparables
Compare Jasper Therapeutics with similar companies based on industry and business-model similarity.
No comparables are published for Jasper Therapeutics. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Jasper Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Jasper Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Balyasny Asset Management L.P. | PIPE |
| Columbia Threadneedle Investments | PIPE |
| Ikarian Capital | PIPE |
| Brahma Capital | PIPE |
| SilverArc Capital Management | PIPE |
| Nazare Partners | PIPE |
| Affinity Asset Advisors | PIPE |
Jasper Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.